EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this mRNA vaccine stop the virus behind mono and MS?
⭐️ VACCINE ⭐️ OngoingThis study tests an experimental mRNA vaccine (mRNA-1189) designed to prevent Epstein-Barr virus (EBV) infection in healthy people aged 10 to 30. Researchers are checking if the vaccine is safe and triggers a strong immune response. About 867 participants will receive either the …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 04:16 UTC
-
New mRNA vaccine aims to stop Epstein-Barr virus in its tracks
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests an experimental mRNA vaccine called mRNA-1195 designed to prevent Epstein-Barr virus (EBV) infection. About 482 healthy adults aged 18 to 55 will receive either the vaccine or a placebo to check for side effects and measure immune responses. The goal …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:13 UTC
-
Blood test may guide chemo choices for nasopharyngeal cancer patients
Disease control OngoingThis study tests whether a blood test for Epstein-Barr virus (EBV) DNA can help doctors choose the best chemotherapy after standard radiation for nasopharyngeal cancer. About 685 patients with advanced but non-spread cancer will first receive standard chemo and radiation. Then, b…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 04:16 UTC